Should Enthusiasm Surrounding Antibiotics Be Tempered?

The market for antibiotics has gained considerable attention over the past few years with an increasing number of development programs and an upturn in the number and value of antibiotic-driven deals. However, this activity may be viewed as overly optimistic as significant challenges for new antibiotic programs still persist—limited diagnostic adoption and an unfavorable reimbursement landscape.